Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: In this study, we assessed the in vitro antischistosomal activity of the active ingredients of (allicin) and (curcumin) on .

Methods: This study was conducted in Faculty of Science, Port said University, Egypt (2018). Adult worms were exposed to a range of concentrations of AL or CU, and worm survival was assessed 24 h post-exposure to calculate the lethal concentration of the compounds. Scanning electron microscopy was used to assess ultrastructural changes in the surface of AL- or CU- treated worms. The genotoxicities of AL and CU on were determined by DNA fragmentation analysis.

Results: We determined the concentrations of AL and CU required to kill 50% of (LC ). The LC of AL was 8.66 μL/mL, whereas 100% mortality of was achieved by AL at concentrations of 50 μL/mL. The LC of CU was 87.25 μL/mL, with the highest mortality of 91.3% seen after 24 h exposure to 100 μg/mL CU. Ultrastructural studies revealed that exposure to either AL or CU led to mild or severe surface damage to , respectively. The degree of damage in the worms was sex-dependent. Interestingly, while CU exposure resulted in DNA fragmentation in worms, we observed no genotoxic effects of AL.

Conclusion: Both AL and CU exhibit antischistosomal activity; the study provided evidence suggesting that these compounds act through distinct mechanisms. These promising results encourage further investigation into these compounds as potential antischistosomal agents, either alone or as complementary treatments to praziquantel.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988669PMC
http://dx.doi.org/10.18502/ijpa.v16i1.5540DOI Listing

Publication Analysis

Top Keywords

antischistosomal activity
12
vitro antischistosomal
8
active ingredients
8
ingredients allicin
8
allicin curcumin
8
dna fragmentation
8
activity genotoxicity
4
genotoxicity active
4
curcumin background
4
background study
4

Similar Publications

Background: Schistosomiasis is a neglected tropical disease caused by parasitic flatworms of the genus Schistosoma. Currently, praziquantel is the only medication available for treating schistosomiasis. However, crucial issues regarding drug resistance, reinfection, and prevention remain unresolved.

View Article and Find Full Text PDF

Discovery of clocinizine as a potential oral drug against Schistosoma mansoni infection.

Sci Rep

August 2025

Núcleo de Pesquisas em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, 07023‑070, Brazil.

Schistosomiasis, a disease caused by parasitic worms, imposes a significant global health burden, affecting over 240 million people, particularly in low-income regions. To meet the Sustainable Development Goals (SDG), the World Health Organization (WHO) emphasize the need for novel antischistosomal agents. In previous work we identified that cinnarizine, a first-generation antihistamine, has promising antischistosomal activity.

View Article and Find Full Text PDF

as a Source of Antiparasitic Agents: and Efficacy against .

ACS Omega

July 2025

Grupo de Pesquisas em Metodologias Sintéticas (GPMS), Departamento de Química, Instituto de Ciências Exatas, Universidade Federal de Juiz de Fora, R. José Lourenço Kelmer s/n, Campus Universitário, Juiz de Fora, MG 36036-900, Brazil.

Schistosomiasis, a neglected tropical disease (NTD) caused by flatworms of the genus , affects more than 250 million people globally. Praziquantel (PZQ) remains the sole therapeutic option, underscoring the need for novel treatments. This study investigates the antischistosomal activity of DC.

View Article and Find Full Text PDF

Schistosomiasis mansoni is a neglected tropical disease caused by the parasite , affecting approximately 200 million people annually. Currently, treatment relies primarily on a single drug, praziquantel (PZQ), which shows limited efficacy against the parasite's immature forms. As a result, Thioredoxin Glutathione Reductase from (SmTGR) has emerged as a promising target for novel drug development.

View Article and Find Full Text PDF

<i>Pseudolachnostylis maprouneifolia</i> Pax is a well-known and widely used medicinal plant in Central and Southern Africa. The current study was aimed at documenting the medicinal uses, phytochemical and pharmacological properties of <i>P. maprouneifolia</i>.

View Article and Find Full Text PDF